# Cogent Biosciences, Inc. (COGT) - Q1 2026 earnings

Reported May 5, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | $500.0 |
| EPS | $-0.53 | $-0.53 |

Earnings filing reader: [8-K 0001193125-26-205124](https://www.opencapital.sh/filings/0001193125-26-205124)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-205124.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1622229/000119312526205124/0001193125-26-205124-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1622229/000119312526205170/0001193125-26-205170-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/cogt/earnings/q1-2026